• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏团队评估在心脏导管实验室中的虚弱程度。

A Heart Team Approach to Assessing Frailty in the Cardiac Catheterization Laboratory.

机构信息

Division of Cardiology, University of Illinois at Chicago, Chicago, IL, United States of America.

Jesse Brown Veterans Affairs Medical Center, Chicago, IL, United States of America.

出版信息

Cardiovasc Revasc Med. 2022 Oct;43:38-42. doi: 10.1016/j.carrev.2022.04.001. Epub 2022 Apr 9.

DOI:10.1016/j.carrev.2022.04.001
PMID:35450810
Abstract

INTRODUCTION

Frailty is a well-documented risk factor for increased morbidity and mortality among patients undergoing percutaneous coronary intervention (PCI). There remains a lack of knowledge regarding the impact of patient frailty in cardiac patient management and outcomes. Thus, this study examined whether the Heart Team, without using frailty assessments, made decisions regarding coronary interventions [medical management (MM) vs. PCI vs. coronary artery bypass grafting (CABG)] that aligned with formally quantified frailty status.

MATERIAL AND METHODS

This cross-sectional quality-improvement (QI) study was performed at a single, large, urban Veterans Affairs Hospital. From September 2019 to November 2020, heart team nurses approached patients prior to coronary angiograms and assessed for frailty using the Risk Analysis Index Questionnaire (RAIC). Interventional cardiologists were blinded to the results. This study's independent variable was RAI-C score. The outcome variables were "intervention performed" (MM, PCI, or CABG) and presence of a "reduced invasiveness intervention" (RI).

RESULTS

Ninety-five of the 182 participants had obstructive coronary artery disease. Among them, there were 69 PCIs, 10 CABGs, and 16 MMs. 26 received RIs. The primary outcomes demonstrated that frailty score was positively associated with receiving RI [adjusted OR = 1.13, 95% CI = 1.02-1.24, p = 0.02] and MM [adjusted OR = 1.13, CI = 1.02-1.25, p = 0.02], and negatively associated with receiving PCI [adjusted OR = 0.94, CI = 0.88-0.998, p = 0.04]. There was no significant association between frailty and the likelihood of undergoing CABG [AOR = 0.95, CI = 0.81-1.10, p = 0.47].

CONCLUSION

This study demonstrated that the Heart Team and patients at baseline reduced high-risk interventions in frailer patients. A Heart Team, shared-decision-making model utilizing the RAI-C was found to be efficient and effective at measuring frailty in coronary angiogram patients and should be considered for use in the clinical setting.

摘要

简介

虚弱是接受经皮冠状动脉介入治疗(PCI)的患者发病率和死亡率增加的一个有据可查的危险因素。关于患者虚弱对心脏患者管理和结局的影响,我们仍然知之甚少。因此,本研究检查了心脏团队在没有使用虚弱评估的情况下,是否根据正式量化的虚弱状况做出了关于冠状动脉介入治疗的决策[药物治疗(MM)与 PCI 与冠状动脉旁路移植术(CABG)]。

材料和方法

这是一项在一家大型城市退伍军人事务医院进行的横断面质量改进(QI)研究。从 2019 年 9 月至 2020 年 11 月,心脏团队护士在冠状动脉造影前接触患者,并使用风险分析指数问卷(RAIC)评估虚弱程度。介入心脏病专家对结果不知情。本研究的自变量是 RAI-C 评分。因变量是“进行的干预”(MM、PCI 或 CABG)和存在“降低侵入性干预”(RI)。

结果

182 名参与者中有 95 名患有阻塞性冠状动脉疾病。其中 69 人接受了 PCI,10 人接受了 CABG,16 人接受了 MM。26 人接受了 RI。主要结果表明,虚弱评分与接受 RI 呈正相关[调整后的 OR = 1.13,95%CI = 1.02-1.24,p = 0.02]和 MM [调整后的 OR = 1.13,CI = 1.02-1.25,p = 0.02],与接受 PCI 呈负相关[调整后的 OR = 0.94,CI = 0.88-0.998,p = 0.04]。虚弱与接受 CABG 的可能性之间没有显著关联[AOR = 0.95,CI = 0.81-1.10,p = 0.47]。

结论

本研究表明,心脏团队和患者在基线时减少了虚弱患者的高危干预措施。发现心脏团队使用 RAI-C 的共同决策模型在测量冠状动脉造影患者的虚弱程度方面是有效和有效的,应考虑在临床环境中使用。

相似文献

1
A Heart Team Approach to Assessing Frailty in the Cardiac Catheterization Laboratory.心脏团队评估在心脏导管实验室中的虚弱程度。
Cardiovasc Revasc Med. 2022 Oct;43:38-42. doi: 10.1016/j.carrev.2022.04.001. Epub 2022 Apr 9.
2
Percutaneous Coronary Intervention in Native Coronary Arteries Versus Bypass Grafts in Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.经皮冠状动脉介入治疗在既往冠状动脉旁路移植术患者中的应用:来自退伍军人事务部临床评估、报告和跟踪计划的见解。
JACC Cardiovasc Interv. 2016 May 9;9(9):884-93. doi: 10.1016/j.jcin.2016.01.034. Epub 2016 Apr 13.
3
Description of a Heart Team approach to coronary revascularization and its beneficial long-term effect on clinical events after PCI.心脏团队冠状动脉血运重建方法及其对PCI术后临床事件的长期有益影响的描述。
Clin Res Cardiol. 2016 May;105(5):388-400. doi: 10.1007/s00392-015-0932-2. Epub 2015 Oct 27.
4
Prior Percutaneous Coronary Intervention and Mortality in Patients Undergoing Surgical Myocardial Revascularization: Results From the E-CABG (European Multicenter Study on Coronary Artery Bypass Grafting) With a Systematic Review and Meta-Analysis.经皮冠状动脉介入治疗与外科血运重建患者的死亡率:E-CABG(欧洲冠状动脉旁路移植术多中心研究)的系统评价和荟萃分析结果。
Circ Cardiovasc Interv. 2018 Feb;11(2):e005650. doi: 10.1161/CIRCINTERVENTIONS.117.005650.
5
Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score.左主干冠状动脉疾病血运重建术根据 SYNTAX 评分。
Circ Cardiovasc Interv. 2019 Sep;12(9):e008007. doi: 10.1161/CIRCINTERVENTIONS.118.008007. Epub 2019 Sep 9.
6
Temporal Trends in Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: Insights From the Washington Cardiac Care Outcomes Assessment Program.经皮冠状动脉介入治疗和冠状动脉旁路移植术的时间趋势:来自华盛顿心脏护理结果评估计划的见解。
J Am Heart Assoc. 2020 Jun 2;9(11):e015317. doi: 10.1161/JAHA.119.015317. Epub 2020 May 27.
7
Comparison of patients with multivessel disease treated at centers with and without on-site cardiac surgery.比较有和无心脏外科手术现场的中心治疗的多血管疾病患者。
J Thorac Cardiovasc Surg. 2018 Mar;155(3):865-873.e3. doi: 10.1016/j.jtcvs.2017.09.144. Epub 2017 Nov 9.
8
Comparison of Heart Team vs Interventional Cardiologist Recommendations for the Treatment of Patients With Multivessel Coronary Artery Disease.多支冠状动脉疾病患者治疗中心脏团队与介入心脏病专家推荐的比较。
JAMA Netw Open. 2020 Aug 3;3(8):e2012749. doi: 10.1001/jamanetworkopen.2020.12749.
9
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with reduced ejection fraction.射血分数降低的患者行经皮冠状动脉介入治疗与冠状动脉旁路移植术的比较。
J Thorac Cardiovasc Surg. 2021 Mar;161(3):1022-1031.e5. doi: 10.1016/j.jtcvs.2020.06.159. Epub 2020 Sep 16.
10
Frailty Trajectories After Treatment for Coronary Artery Disease in Older Patients.老年患者冠状动脉疾病治疗后的衰弱轨迹
Circ Cardiovasc Qual Outcomes. 2016 May;9(3):230-8. doi: 10.1161/CIRCOUTCOMES.115.002204. Epub 2016 May 10.

引用本文的文献

1
Functional Mitral Regurgitation in the Transcatheter Era: Diagnostic and Therapeutic Pathways.经导管时代的功能性二尖瓣反流:诊断与治疗途径
J Pers Med. 2025 Aug 13;15(8):372. doi: 10.3390/jpm15080372.
2
Clinical and Biological Markers of Frailty Syndrome in Patients Undergoing Elective Percutaneous Coronary Intervention.接受择期经皮冠状动脉介入治疗患者衰弱综合征的临床和生物学标志物
Diagnostics (Basel). 2024 Nov 26;14(23):2663. doi: 10.3390/diagnostics14232663.
3
Assessment and Management of Older Adults Undergoing PCI, Part 1: A Expert Panel.
接受经皮冠状动脉介入治疗的老年人的评估与管理,第1部分:专家小组。
JACC Adv. 2023 Jun;2(4). doi: 10.1016/j.jacadv.2023.100389.